GLOW and KLOW are built around skin-remodeling goals, not structural injury rehabilitation
Research models cover traumatic brain injury, hippocampal ischemia, cuprizone-induced demyelination (a multiple sclerosis model), and spinal cord compression injury with tail paralysis
Potential contribution of NF-kappaB in neuronal cell death in the glutathione peroxidase-1 knockout mouse in response to ischemia-reperfusion injury
Consistently, increased global cysteine sulfenylation was detected
Human data is limited but promising: Preclinical Studies : Over 100 publications, including those on PubMed, show BPC-157's efficacy in models of wound healing, GI protection, and CNS recovery
There have been concerns that having the MTHFR variation or elevated homocysteine levels could potentially interfere with future insurance coverage, that may limit pre-existing conditions